Article Text

other Versions

PDF
Effects of aflibercept on primary RPE cells: toxicity, wound healing, uptake and phagocytosis
  1. Alexa Klettner,
  2. Nihat Tahmaz,
  3. Michaela Dithmer,
  4. Elisabeth Richert,
  5. Johann Roider
  1. Department of Ophthalmology, University of Kiel, University Medical Center, Kiel, Germany
  1. Correspondence to Professor Alexa Klettner, Department of Ophthalmology, University of Kiel, University Medical Center, Arnold-Heller-Str. 3, Kiel 24105, Germany; aklettner{at}auge.uni-kiel.de

Abstract

Background/aim Anti-VEGF treatment is the therapy of choice in age-related macular degeneration, and is also applied in diabetic macular oedema or retinal vein occlusion. Recently, the fusion protein, aflibercept, has been approved for therapeutic use. In this study, we investigate the effects of aflibercept on primary RPE cells.

Methods Primary RPE cells were prepared from freshly slaughtered pigs’ eyes. The impact of aflibercept on cell viability was investigated with MTT and trypan blue exclusion assay. The influence of aflibercept on wound healing was assessed with a scratch assay. Intracellular uptake of aflibercept was investigated in immunohistochemistry and its influence on phagocytosis with a phagocytosis assay using opsonised latex beads.

Results Aflibercept displays no cytotoxicity on RPE cells but impairs its wound healing ability. It is taken up into RPE cells and can be intracellularly detected for at least 7 days. Intracellular aflibercept impairs the phagocytic capacity of RPE cells.

Conclusions Aflibercept interferes with the physiology of RPE cells, as it is taken up into RPE cells, which is accompanied by a reduction of the phagocytic ability. Additionally, it impairs the wound healing capacity of RPE cells. These effects on the physiology of RPE cells may indicate possible side effects.

  • Pharmacology
  • Wound healing
  • Retina

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • At a glance
    Keith Barton James Chodosh Jost Jonas